Saudi Pharmaceutical Appliances (2070)

Currency in SAR
29.74
-0.72(-2.36%)
Closed·
Earnings results expected in 12 days
2070 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.0030.40
52 wk Range
21.7633.12
Key Statistics
Bid/Ask
29.74 / 29.80
Prev. Close
30.46
Open
30.4
Day's Range
29-30.4
52 wk Range
21.76-33.12
Volume
817.12K
Average Volume (3m)
682.93K
1-Year Change
18.062%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2070 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
31.20
Upside
+4.91%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts predict the company will be profitable this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

0 Buy
3 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 31.20
(+4.91% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
31/03/2026
EPS / Forecast
0.32 / --
Revenue / Forecast
424M / --
EPS Revisions
Last 90 days

Compare 2070 to Peers and Sector

Metrics to compare
2070
Peers
Sector
Relationship
P/E Ratio
19.7x10.0x−0.5x
PEG Ratio
0.030.100.00
Price/Book
2.3x2.9x2.6x
Price / LTM Sales
2.1x2.2x3.2x
Upside (Analyst Target)
7.0%31.6%48.3%
Fair Value Upside
Unlock9.7%5.6%Unlock

Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, and Morocco. The company operates through Pharmaceutical Manufacturing, Trading and Distribution Services, and Healthcare Services segments. The company is involved in the sale, marketing, and distribution of pharmaceutical, veterinary, medical equipment, and cosmetics products; and operates and maintains a secondary care hospital. In addition, it manufactures human medicines, and wholesales and retails of medicines and related products. Further, the company engages in the research and development of medical science activities, and investment business in related industries. The company was incorporated in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.15M4.32%156.97M
Other Institutional Investors
24.59M20.60%748.88M
Public Companies & Retail Investors
89.62M75.08%2.73B
Total
119.35M100.00%3.64B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Arab Company for Drug Industries & Medical Supplies20.60%24,585,600748,877
The Vanguard Group, Inc.2.09%2,489,32275,825

People Also Watch

FAQ

What Is the SPIMACO (Saudi Arabia: 2070) Share Price Today?

The SPIMACO stock price today is 29.74 SAR.

What Stock Exchange Does SPIMACO (2070) Trade On?

SPIMACO is listed and trades on the Saudi Arabia Stock Exchange.

What Is the Ticker (Stock Symbol) for SPIMACO?

The stock symbol (also called a 'ticker') for SPIMACO is "2070."

What Is the Current SPIMACO Market Capitalisation?

As of today, SPIMACO (Saudi Arabia: 2070) market cap is 3.55B SAR.

What Is SPIMACO's (2070) Earnings Per Share (TTM)?

The SPIMACO EPS is currently 1.54 (Trailing Twelve Months).

When Is the Next SPIMACO Earnings Date?

SPIMACO's next earnings report will be released on 19/05/2026.

Is 2070 a Buy or Sell From a Technical Analyst Perspective?

Based on today's SPIMACO moving averages and other technical indicators, the daily buy/sell signal for 2070 stock is Strong Sell.

How Many Times Has SPIMACO Stock Split?

SPIMACO has split 3 times. (See the 2070 stock split history page for full effective split date and price information.)

What is the current trading status of SPIMACO (Saudi Arabia: 2070)?

As of 07/05/2026, SPIMACO (2070) is trading at a share price of 29.74 SAR, with a previous close of 30.46 SAR. The stock has fluctuated within a day range of 29.00 SAR to 30.40 SAR, while its 52-week range spans from 21.76 SAR to 33.12 SAR.

What Is SPIMACO (2070) Price Target According to Analysts?

The average 12-month price target for SPIMACO is 31.20 SAR, with a high estimate of 33 SAR and a low estimate of 28 SAR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +4.91% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.